Columbia University experience of detection of circulating cells by RT-PCR PSa in prostate cancer as a predictive factor of stage and biochemical recurrence;Expérience de l'Université de Columbia dans la détection des cellules circulantes par RT-PCR PSA dans le cancer de prostate comme facteur prédictif du stade et de la récurrence biologique

Progres en Urologie

Volumn 9, Issue 3, 1999, Pages 555-561

  De La Taille, Alexandre ^a   Olsson, Carl A ^a   Buttyan, Ralph ^a   Bagiella, Emilia ^b   Cao, Yichen ^a   Burchardt, Tatjana ^a   Katz, Aaron E ^a  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b Atchley Pavilion ^*

Author keywords

Follow up; Prostate cancer; Prostatic Specific Antigen (PSA); Radical prostatectomy; RT PCR

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; PROSTATECTOMY; REPRODUCIBILITY; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL;

ADULT; AGED; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 0033144335     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. CAMA C., OLSSON C.A., BUTTYAN R., DE VRIES G.M., WISE G.J., KATZ A.E. Molecular staging of prostate cancer. III. Effects of cystoscopy and needle biopsy on the enhanced reverse transcriptase polymerase chain reaction assay. J. Urol., 1997, 157, 1748-1751.
2. COREY E., ARFMAN E.W., OSWIN M.M., MELCHIOR S.W., TINDALL D.J., YOUNG C.Y., ELLIS W.J., VESSELLA R.L. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages. Urology, 1997, 50, 184-188.
3. DE CREMOUX P., RAVERY V., PODGORNIAK M.P., CHEVILLARD S., TOUBLANC M., THIOUNN N., TATOUD R., DELMAS V., CALVO T., BOCCON-GIBOD L. Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. Eur. Urol., 1997, 32, 69-74.
4. DE LA TAILLE A., COLOMBEL M., AMSELLEM S., MUSCATELLI B., RADVANYI F., MAZEMAN E., ABBOU C.C., CHOPIN D. Gène du PSA : Intérêt dans la détection des cellules circulantes dans le cancer de la prostate. Progrès en Urologie, 1997, 7, 930-936.
5. DE LA TAILLE A., OLSSON C.A., KATZ A.E. RT-PCR for PSA-Molecular staging of prostate cancer: dream or reality ?" Oncology, 1999, in press.
6. DE LA TAILLE A., MUSCATELLI B., COLOMBEL M., JOUAULT H., AMSELEM S., MAZEMAN E., ABBOU C.C., CHOPIN D. Détection in vitro des cellules circulantes dans le cancer de la prostate par immunocytochimie, cytométrie en flux et RT-PCR PSA. Prog. Urol., 1998, 8, 1058-1064.
7. ELLIS W.J., VESSELLA R.L., COREY E., ARFMAN E.W., OSWIN M.M., MELCHIOR S., LANGE P.H. The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and follow-up of patients with prostate cancer. J. Urol, 1998, 159, 1134-1138.
8. ESCHWEGE P., DUMAS F., BLANCHET P., BENOIT G., JARDIN A., LORIC S. Cellules circulantes et cancer de prostate: interêt en pratique quotidienne. Sémin. Urol. Néphrol., 1997, 23, 287-290.
9. GHOSSEIN R.A., ROSAI J., SCHER H.I., SEIDEN M., ZHANG Z.F., SUN M., CHANG G., BERLANE K., KRITHIVAS K., KANTOFF P.W. Prognostic significance of detection of prostate-specific antigen transcripts in the peripheral blood of patients with metastatic androgen-independent prostatic carcinoma. Urology, 1997, 50, 100-105.
10. GOMELLA L.G., RAJ G.V., MORENO J.G. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer. J. Urol., 1997, 158, 326-337.
11. GRASSO Y.Z., GUPTA M.K., LEVIN H.S., ZIPPE C.D., KLEIN E.A. Combined nested RT-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in prostate cancer patients: correlation with pathological stage. Cancer Res., 1998, 58, 1456-1459.
12. ISRAELI R.S., MILLER W.H., SU S.L., POWELL C.T., FAIR W.R., SAMADI D.S., HURYK R.F., DEBLASIO A., EDWARDS E.T., WISE G.J. Sensitive nested reverse transcriptase polymerase chain reaction detection of circulating prostate tumor cells: comparison of prostate specific membrane antigen and prostate specific antigen based assays. Cancer Res., 1994 54, 6306-6310.
13. JAAKKOLA S., VORNANEN T., LEINONEN J., RANNIKKO S., STENMAN U.H. Detection of prostatic cells in peripheral blood: correlation with serum concentrations of prostate specific antigen. Clin. Chem., 1995, 41, 182-186.
14. JONASSON O., LONG L., ROBERTS S., MCGREW E., MCDONALD J.H. Cancer cells in the circulating blood during operative management of genitourinary tumors. J. Urol., 1961, 85; 1-6.
15. KATZ A.E., OLSSON C.A., RAFFO A.J., CAMA C., PERLMAN H., SEAMAN E., O'TOOLE K.M., MCMAHON D., BENSON M.C., BUTTYAN R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 1994, 43, 765-775.
16. KATZ A.E., DE VRIES G.M., BENSON M.C., BUTTYAN R., O'TOOLE K.M., RUBIN M.A., STIFELMAN M., OLSSON C.A. The role of the reverse-transcriptase polymerase chain reaction assay for prostate-specific antigen in the selection of patients for radical prostatectomy. Urol. Clin. N. Am., 1996, 23, 541-549.
17. KAWAKAMI M., OKANEYA T., FURIHATA K., NISHIZAWA O., KATSUYAMA T. Detection of prostate cancer cells circulating in peripheral blood by reverse transcription-PCR for hKLK2. Cancer Res., 1997, 57, 4167-4170.
18. LORIC S., DUMAS F., ESCHWEGE P., BLANCHET P., BENOIT G., JARDIN A., LACOUR B. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen. Clin. Chem., 1995, 41, 1698-1704.
19. MORENO J.G., CROCE C.M., FISHER R, MONNE M., VIHKO P., MULHOLLAND S.G., GOMELLA L.G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 1992, 52, 6110-6112.
20. NEJAT R.J., KATZ A.E., OLSSON C.A. The role of reverse transcriptase-polymerase chain reaction for staging patients with clinically localized prostate cancer. Semin. Urol. Oncol., 1998 16, 40-45.
21. NOGUCHI M., MIYAJIMA J., ITOH K., NODA S. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction. Int. J. Urol., 1997 4, 374-379.
22. OLSSON C.A., DE VRIES G.M., RAFFO A.J., BENSON M.C., O'TOOLE K.M., CAO Y., BUTTYAN R., KATZ A.E. Preoperative reverse transcriptase polymerase chain reaction for prostate specific antigen predicts treatment failure following radical prostatectomy. J. Urol., 1996 155, 1557-1562.
23. OLSSON C.A., DE VRIES G.M., BENSON M.C., RAFFO A., BUTTYAN R., CAMA C., O'TOOLE K.M., KATZ A.E. The use of RT-PCR for prostate-specific antigen assay to predict potential surgical failures before radical prostatectomy: molecular staging of prostate cancer. Br. J. Urol., 1996, 77, 411-417.
24. RAVERY V., DE LA TAILLE A., TOUBLANC M., BOCCON-GIBOD L., HERMIEU J.F., DELMAS V., BOCCON-GIBOD L. Prostate specimen reevaluation in patients with organ confined prostate cancer and postoperative biological recurrence. J. Urol., 1996, 155, 1981-1982.
25. SEIDEN M.V., KANTOFF P.W., KRITHIVAS K., PROPERT K., BRYANT M., HALTOM E., GAYNES L., KAPLAN I., BUBLEY G., DEWOLF W. Detection of circulating tumor cells in men with localized prostate cancer. J. Clin. Oncol., 1994, 12, 2634-2639.
26. SOKOLOFF M.H., TSO C.L., KABOO R., NELSON S., KO J., DOREY F., FIGLIN R.A., PANG S., DEKERNION J., BELLDEGRUN A. Quantitative polymerase chain reaction does not improve preoperative cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 1996, 156, 1560-1566.
27. THIOUNN N., SAPORTA F., FLAM T.A., PAGES F., ZERBIB M., VIEILLEFOND A., MARTIN E., DEBRE B., CHEVILLARD S. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology, 1997, 50, 245-250.
28. VAN NGUYEN C., SONG W., SCARDINO P.T., WHEELER T.M., KATTAN M.W., SLAWIN K.M. RT-PCR for PSA and hK2: implications for staging and patient management in men undergoing radical prostatectomy. J. Urol., 1998, 159, 292A, abstract 1114.
29. VESSELA R.L., LANGE P.H., BLUMENSTEIN B.A., GOMELLA L.G., MORENO J.G., WOOD D.P., BEAMAN A., MOUL J.W., SRIVASTAVA S., SLAWIN K.M., SCARDINO P.T., BUTTYAN R., KATZ A.E., OLSSON C.A., HESTON W.D., FAIR W.R., O'HARA M., VELTRI R.W. Multicenter RT-PCR PSA clinical trial for preoperative staging of prostate cancer J. Urol., 1998, 159, 292A, abstract 1124.
30. WOOD D.P., BANERJEE M. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease-free survival. J. Clin. Oncol., 1997, 15, 3451-3455.